133 related articles for article (PubMed ID: 33760311)
1. Factors and glucocorticoid usage affecting the prognosis of systemic juvenile idiopathic arthritis.
Paç Kısaarslan A; Özdemir Çiçek S; Şahin N; Başol M; Doğantan Ş; Taşkın SN; Poyrazoğlu MH
Pediatr Int; 2021 Dec; 63(12):1424-1432. PubMed ID: 33760311
[TBL] [Abstract][Full Text] [Related]
2. Systemic onset juvenile idiopathic arthritis: a single center experience.
Sağ E; Uzunoğlu B; Bal F; Sönmez HE; Demir S; Bilginer Y; Özen S
Turk J Pediatr; 2019; 61(6):852-858. PubMed ID: 32134578
[TBL] [Abstract][Full Text] [Related]
3. Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany.
Hinze CH; Holzinger D; Lainka E; Haas JP; Speth F; Kallinich T; Rieber N; Hufnagel M; Jansson AF; Hedrich C; Winowski H; Berger T; Foeldvari I; Ganser G; Hospach A; Huppertz HI; Mönkemöller K; Neudorf U; Weißbarth-Riedel E; Wittkowski H; Horneff G; Foell D;
Pediatr Rheumatol Online J; 2018 Jan; 16(1):7. PubMed ID: 29357887
[TBL] [Abstract][Full Text] [Related]
4. The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013.
Janow G; Schanberg LE; Setoguchi S; Hasselblad V; Mellins ED; Schneider R; Kimura Y;
J Rheumatol; 2016 Sep; 43(9):1755-62. PubMed ID: 27307527
[TBL] [Abstract][Full Text] [Related]
5. Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course.
Hügle B; Hinze C; Lainka E; Fischer N; Haas JP
Pediatr Rheumatol Online J; 2014; 12():28. PubMed ID: 25114627
[TBL] [Abstract][Full Text] [Related]
6. Predictors of disease course in systemic juvenile idiopathic arthritis.
Kaplan MM; Tekin ZE; Çelikel E; Güngörer V; Karagöl C; Öner N; Polat MC; Öztürk D; Özçelik E; Ekici MI; Acar BÇ
Mod Rheumatol; 2024 Apr; ():. PubMed ID: 38590038
[TBL] [Abstract][Full Text] [Related]
7. The frequency of macrophage activation syndrome and disease course in systemic juvenile idiopathic arthritis.
Çakan M; Karadağ ŞG; Tanatar A; Ayaz NA
Mod Rheumatol; 2020 Sep; 30(5):900-904. PubMed ID: 31462146
[No Abstract] [Full Text] [Related]
8. Systemic juvenile idiopathic arthritis versus adult-onset Still´s disease: the pertinence of changing the current classification criteria.
Silva JR; Brito I
Acta Reumatol Port; 2020; 45(2):150-151. PubMed ID: 32895357
[TBL] [Abstract][Full Text] [Related]
9. The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis.
Aljaberi N; Tronconi E; Schulert G; Grom AA; Lovell DJ; Huggins JL; Henrickson M; Brunner HI
Pediatr Rheumatol Online J; 2020 Jan; 18(1):7. PubMed ID: 31948488
[TBL] [Abstract][Full Text] [Related]
10. Systemic Juvenile Idiopathic Arthritis.
Lee JJY; Schneider R
Pediatr Clin North Am; 2018 Aug; 65(4):691-709. PubMed ID: 30031494
[TBL] [Abstract][Full Text] [Related]
11. Disease evolution in systemic juvenile idiopathic arthritis: an international, observational cohort study through JIRcohort.
Wallimann M; Bouayed K; Cannizzaro E; Kaiser D; Belot A; Merlin E; Poignant S; Wouters C; Hofer F; Saurenmann T; Koryllou A; Carlomagno R; Mejbri M; Hofer M; Theodoropoulou K
Pediatr Rheumatol Online J; 2023 Sep; 21(1):96. PubMed ID: 37679749
[TBL] [Abstract][Full Text] [Related]
12. JAK inhibitors in systemic juvenile idiopathic arthritis.
He T; Xia Y; Luo Y; Yang J
Front Pediatr; 2023; 11():1134312. PubMed ID: 37152309
[TBL] [Abstract][Full Text] [Related]
13. Clinical profile and juvenile arthritis damage index in children with juvenile idiopathic arthritis: A study from a tertiary care center in south India.
Menon NVB; Peethambaran G; Puthiyapurayil AT; Nambudakath C; Arakkal R
Int J Rheum Dis; 2018 Apr; 21(4):871-879. PubMed ID: 27309679
[TBL] [Abstract][Full Text] [Related]
14. Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience.
Barut K; Adrovic A; Sahin S; Tarcin G; Tahaoglu G; Koker O; Yildiz M; Kasapcopur O
Int J Rheum Dis; 2019 Sep; 22(9):1661-1669. PubMed ID: 31273940
[TBL] [Abstract][Full Text] [Related]
15. Effect of first-line biologic initiation on glucocorticoid exposure in children hospitalized with new-onset systemic juvenile idiopathic arthritis: emulation of a pragmatic trial using observational data.
Peterson RG; Xiao R; Katcoff H; Fisher BT; Weiss PF
Pediatr Rheumatol Online J; 2021 Jul; 19(1):109. PubMed ID: 34225753
[TBL] [Abstract][Full Text] [Related]
16. Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review.
Chantarogh S; Vilaiyuk S; Tim-Aroon T; Worawichawong S
BMC Nephrol; 2017 May; 18(1):159. PubMed ID: 28499374
[TBL] [Abstract][Full Text] [Related]
17. Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST).
Nigrovic PA; Beukelman T; Tomlinson G; Feldman BM; Schanberg LE; Kimura Y;
Clin Trials; 2018 Jun; 15(3):268-277. PubMed ID: 29542334
[TBL] [Abstract][Full Text] [Related]
18. The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives.
Toplak N; Blazina Š; Avčin T
Drug Des Devel Ther; 2018; 12():1633-1643. PubMed ID: 29922038
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid treatment in juvenile idiopathic arthritis.
Batu ED
Rheumatol Int; 2019 Jan; 39(1):13-27. PubMed ID: 30276425
[TBL] [Abstract][Full Text] [Related]
20. Outcomes and predictors of juvenile idiopathic arthritis in Southeast Asia: a Singapore longitudinal study over a decade.
Teh KL; Tanya M; Das L; Hoh SF; Gao X; Arkachaisri T
Clin Rheumatol; 2021 Jun; 40(6):2339-2349. PubMed ID: 33236179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
